Literature DB >> 1898980

Smoking-attributable mortality and years of potential life lost--United States, 1988.

.   

Abstract

Smoking is a leading cause of diseases associated with premature mortality in the United States; in 1985, these diseases accounted for an estimated 390,000 premature deaths. In this report, mortality data and estimates of smoking prevalence for 1988 are used to calculate smoking-attributable mortality (SAM), years of potential life lost (YPLL), and age-adjusted SAM and YPLL rates for the United States. Calculations were performed using Smoking-Attributable Mortality, Morbidity, and Economic Cost (SAMMEC II) software, which includes relative risk estimates for 22 adult (i.e., greater than or equal to 35 years of age) smoking-related diseases and relative risk estimates for four perinatal (i.e., less than 1 year of age) conditions. Age-, sex-, and race-specific mortality data for 1988 were obtained from CDC's National Center for Health Statistics. Data on burn deaths caused by cigarettes were obtained from the Federal Emergency Management Agency. The estimated number of deaths among nonsmokers from lung cancer attributable to passive smoking was obtained from a report of the National Academy of Sciences. Age-, sex-, and race-specific current and former smoking prevalence rates in 1988 for adults aged greater than or equal to 35 years and for women aged 18-44 years were estimated by linear extrapolation using National Health Interview Survey data for 1974-1987.

Entities:  

Mesh:

Year:  1991        PMID: 1898980

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  10 in total

1.  Communitywide smoking prevention: long-term outcomes of the Minnesota Heart Health Program and the Class of 1989 Study.

Authors:  C L Perry; S H Kelder; D M Murray; K I Klepp
Journal:  Am J Public Health       Date:  1992-09       Impact factor: 9.308

2.  Brand switching or reduced consumption? A study of how cigarette taxes affect tobacco consumption.

Authors:  Chiang-Ming Chen; Kuo-Liang Chang; Lin Lin; Jwo-Leun Lee
Journal:  Eur J Health Econ       Date:  2013-12-12

3.  Reducing the illegal sales of cigarettes to minors: analysis of alternative enforcement schedules.

Authors:  L Jason; W Billows; D Schnopp-Wyatt; C King
Journal:  J Appl Behav Anal       Date:  1996

4.  Comments on a positive health practice observed in African-American youth.

Authors:  G Dawson
Journal:  J Natl Med Assoc       Date:  1996-08       Impact factor: 1.798

5.  What scientists funded by the tobacco industry believe about the hazards of cigarette smoking.

Authors:  K M Cummings; R Sciandra; A Gingrass; R Davis
Journal:  Am J Public Health       Date:  1991-07       Impact factor: 9.308

6.  Impact of age at smoking initiation, dosage, and time since quitting on cardiovascular disease in african americans and whites: the atherosclerosis risk in communities study.

Authors:  Rachel R Huxley; Hiroshi Yatsuya; Pamela L Lutsey; Mark Woodward; Alvaro Alonso; Aaron R Folsom
Journal:  Am J Epidemiol       Date:  2012-03-06       Impact factor: 4.897

7.  Cancer prevention behaviors among African-American adults: a survey of wards 7 and 8 in Washington, DC.

Authors:  S Shankar; V Y Kofie; K Helzlsouer; M L Rivo; G Bonney
Journal:  J Natl Med Assoc       Date:  1995-01       Impact factor: 1.798

Review 8.  Lifestyle factors and stroke risk: exercise, alcohol, diet, obesity, smoking, drug use, and stress.

Authors:  B Boden-Albala; R L Sacco
Journal:  Curr Atheroscler Rep       Date:  2000-03       Impact factor: 5.967

9.  Using the National Health Interview Survey to understand and address the impact of tobacco in the United States: past perspectives and future considerations.

Authors:  Cathy L Backinger; Deirdre Lawrence; Judith Swan; Deborah M Winn; Nancy Breen; Anne Hartman; Rachel Grana; David Tran; Samantha Farrell
Journal:  Epidemiol Perspect Innov       Date:  2008-12-04

10.  The disease burden attributable to smoking in the state of Rio de Janeiro, Brazil in 2000.

Authors:  Andreia Ferreira Oliveira; Joaquim Gonçalves Valente; Iuri Costa Leite
Journal:  Clinics (Sao Paulo)       Date:  2008-04       Impact factor: 2.365

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.